.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent Right to Information (RTI) data reveals that the National Immunisation Programme faces persistent financial underutilization. Although the Indian government allocates thousands of crores annually, a significant portion remains unspent by state health departments. Consequently, this creates questions regarding the implementation efficiency of one of the world's largest public health initiatives. Doctors and public health experts must understand these fiscal trends to advocate for better resource management at the ground level.
Budgetary data for the 2024-25 period shows a sanctioned amount of Rs 3,186 crore, yet actual expenditure was only Rs 1,971 crore. This trend appears to persist into the 2025-26 fiscal year. Provisional figures indicate that only Rs 1,060 crore has been utilized against a sanctioned Rs 3,434 crore. These gaps often arise from fragmented record-keeping and delays in state-level monitoring reports. Therefore, streamlining data systems is essential for improving financial accountability and service delivery.
Despite financial hurdles, India has achieved remarkable success in expanding its reach. Full immunisation coverage surged from 88.2% in 2021-22 to 98.1% by 2024-25. Furthermore, approximately 2.5 crore children receive life-saving vaccines annually against diseases like polio and hepatitis B. However, experts suggest that the programme should expand to include typhoid and influenza vaccines. Additionally, improving gender-specific data collection will help ensure that no child is left behind due to systemic gaps.
Q1: Which vaccines are provided for free under India's national programme?
The programme offers free protection against multiple diseases, including polio, measles, hepatitis B, and tuberculosis. It aims to protect approximately 26 million newborns annually.
Q2: Why is the full expenditure of sanctioned funds often delayed?
Delays often occur due to fragmented data reporting from states and UTs. Furthermore, administrative bottlenecks in monitoring and procurement can lead to significant portions of the budget remaining unspent.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
RTI data reveals significant unspent funds in India's National Immunisation Programme despite a 98.1% coverage rate, highlighting implementation challenges....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
